Yinping Sun
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Micellar co-delivery of KRAS-mutant inhibitors and TLR7/8 agonists synergizes targeted therapy and immunotherapy in lung cancer.
Journal: Acta biomaterialia
Published: September 02, 2025
Intranasal and Intravenous Sequential Administration of Survivin Peptide-CpG Nanovaccines Elicits Potent Immunity Toward Glioblastoma.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: December 31, 2024
Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 08, 2024
A Biomimetic Autophagosomes-Based Nanovaccine Boosts Anticancer Immunity.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: July 04, 2024
Uplifting Antitumor Immunotherapy with Lymph-Node-Targeted and Ratio-Controlled Codelivery of Tumor Cell Lysate and Adjuvant.
Journal: Advanced healthcare materials
Published: October 25, 2023
CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Journal: Acta biomaterialia
Published: November 22, 2021
Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.
Journal: Theranostics
Published: May 31, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026